Global Opioids Drugs Market Research Report 2020

Global Opioids Drugs Market Research Report 2020

Table of Contents
1 Opioids Drugs Market Overview
1.1 Product Overview and Scope of Opioids Drugs
1.2 Opioids Drugs Segment by Type
1.2.1 Global Opioids Drugs Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.2.6 Other
1.3 Opioids Drugs Segment by Application
1.3.1 Opioids Drugs Sales Comparison by Application: 2020 VS 2026
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Other
1.4 Global Opioids Drugs Market Size Estimates and Forecasts
1.4.1 Global Opioids Drugs Revenue 2015-2026
1.4.2 Global Opioids Drugs Sales 2015-2026
1.4.3 Opioids Drugs Market Size by Region: 2020 Versus 2026
2 Global Opioids Drugs Market Competition by Manufacturers
2.1 Global Opioids Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Opioids Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Opioids Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Opioids Drugs Manufacturing Sites, Area Served, Product Type
2.5 Opioids Drugs Market Competitive Situation and Trends
2.5.1 Opioids Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Opioids Drugs Players (Opinion Leaders)
3 Opioids Drugs Retrospective Market Scenario by Region
3.1 Global Opioids Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Opioids Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Opioids Drugs Market Facts & Figures by Country
3.3.1 North America Opioids Drugs Sales by Country
3.3.2 North America Opioids Drugs Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Opioids Drugs Market Facts & Figures by Country
3.4.1 Europe Opioids Drugs Sales by Country
3.4.2 Europe Opioids Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Opioids Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Opioids Drugs Sales by Region
3.5.2 Asia Pacific Opioids Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Opioids Drugs Market Facts & Figures by Country
3.6.1 Latin America Opioids Drugs Sales by Country
3.6.2 Latin America Opioids Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Opioids Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Opioids Drugs Sales by Country
3.7.2 Middle East and Africa Opioids Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Opioids Drugs Historic Market Analysis by Type
4.1 Global Opioids Drugs Sales Market Share by Type (2015-2020)
4.2 Global Opioids Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Opioids Drugs Price Market Share by Type (2015-2020)
4.4 Global Opioids Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Opioids Drugs Historic Market Analysis by Application
5.1 Global Opioids Drugs Sales Market Share by Application (2015-2020)
5.2 Global Opioids Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Opioids Drugs Price by Application (2015-2020)
6 Company Profiles and Key Figures in Opioids Drugs Business
6.1 Purdue Pharma
6.1.1 Corporation Information
6.1.2 Purdue Pharma Description, Business Overview and Total Revenue
6.1.3 Purdue Pharma Opioids Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Purdue Pharma Products Offered
6.1.5 Purdue Pharma Recent Development
6.2 J&J
6.2.1 J&J Opioids Drugs Production Sites and Area Served
6.2.2 J&J Description, Business Overview and Total Revenue
6.2.3 J&J Opioids Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 J&J Products Offered
6.2.5 J&J Recent Development
6.3 Teva
6.3.1 Teva Opioids Drugs Production Sites and Area Served
6.3.2 Teva Description, Business Overview and Total Revenue
6.3.3 Teva Opioids Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Teva Products Offered
6.3.5 Teva Recent Development
6.4 Mylan
6.4.1 Mylan Opioids Drugs Production Sites and Area Served
6.4.2 Mylan Description, Business Overview and Total Revenue
6.4.3 Mylan Opioids Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Mylan Products Offered
6.4.5 Mylan Recent Development
6.5 Depomed
6.5.1 Depomed Opioids Drugs Production Sites and Area Served
6.5.2 Depomed Description, Business Overview and Total Revenue
6.5.3 Depomed Opioids Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Depomed Products Offered
6.5.5 Depomed Recent Development
6.6 INSYS
6.6.1 INSYS Opioids Drugs Production Sites and Area Served
6.6.2 INSYS Description, Business Overview and Total Revenue
6.6.3 INSYS Opioids Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 INSYS Products Offered
6.6.5 INSYS Recent Development
6.7 Endo
6.6.1 Endo Opioids Drugs Production Sites and Area Served
6.6.2 Endo Description, Business Overview and Total Revenue
6.6.3 Endo Opioids Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Endo Products Offered
6.7.5 Endo Recent Development
6.8 Pfizer
6.8.1 Pfizer Opioids Drugs Production Sites and Area Served
6.8.2 Pfizer Description, Business Overview and Total Revenue
6.8.3 Pfizer Opioids Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Pfizer Products Offered
6.8.5 Pfizer Recent Development
6.9 Hikma
6.9.1 Hikma Opioids Drugs Production Sites and Area Served
6.9.2 Hikma Description, Business Overview and Total Revenue
6.9.3 Hikma Opioids Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Hikma Products Offered
6.9.5 Hikma Recent Development
6.10 Mallinckrodt
6.10.1 Mallinckrodt Opioids Drugs Production Sites and Area Served
6.10.2 Mallinckrodt Description, Business Overview and Total Revenue
6.10.3 Mallinckrodt Opioids Drugs Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Mallinckrodt Products Offered
6.10.5 Mallinckrodt Recent Development
6.11 Pernix
6.11.1 Pernix Opioids Drugs Production Sites and Area Served
6.11.2 Pernix Opioids Drugs Description, Business Overview and Total Revenue
6.11.3 Pernix Opioids Drugs Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Pernix Products Offered
6.11.5 Pernix Recent Development
6.12 Egalet
6.12.1 Egalet Opioids Drugs Production Sites and Area Served
6.12.2 Egalet Opioids Drugs Description, Business Overview and Total Revenue
6.12.3 Egalet Opioids Drugs Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Egalet Products Offered
6.12.5 Egalet Recent Development
6.13 Vistapharm
6.13.1 Vistapharm Opioids Drugs Production Sites and Area Served
6.13.2 Vistapharm Opioids Drugs Description, Business Overview and Total Revenue
6.13.3 Vistapharm Opioids Drugs Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Vistapharm Products Offered
6.13.5 Vistapharm Recent Development
7 Opioids Drugs Manufacturing Cost Analysis
7.1 Opioids Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Opioids Drugs
7.4 Opioids Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Opioids Drugs Distributors List
8.3 Opioids Drugs Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Opioids Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Opioids Drugs by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Opioids Drugs by Type (2021-2026)
10.2 Opioids Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Opioids Drugs by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Opioids Drugs by Application (2021-2026)
10.3 Opioids Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Opioids Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Opioids Drugs by Region (2021-2026)
10.4 North America Opioids Drugs Estimates and Projections (2021-2026)
10.5 Europe Opioids Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Opioids Drugs Estimates and Projections (2021-2026)
10.7 Latin America Opioids Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Opioids Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Opioids Drugs Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Opioids Drugs Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Opioids Drugs Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Opioids Drugs Manufacturers Covered in This Study
Table 5. Global Opioids Drugs Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Opioids Drugs Sales Share by Manufacturers (2015-2020)
Table 7. Global Opioids Drugs Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Opioids Drugs Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Opioids Drugs Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Opioids Drugs Sales Sites and Area Served
Table 11. Manufacturers Opioids Drugs Product Types
Table 12. Global Opioids Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Opioids Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioids Drugs as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Opioids Drugs Players
Table 16. Global Opioids Drugs Sales (K Units) by Region (2015-2020)
Table 17. Global Opioids Drugs Sales Market Share by Region (2015-2020)
Table 18. Global Opioids Drugs Revenue (Million US$) by Region (2015-2020)
Table 19. Global Opioids Drugs Revenue Market Share by Region (2015-2020)
Table 20. North America Opioids Drugs Sales by Country (2015-2020) (K Units)
Table 21. North America Opioids Drugs Sales Market Share by Country (2015-2020)
Table 22. North America Opioids Drugs Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Opioids Drugs Revenue Market Share by Country (2015-2020)
Table 24. Europe Opioids Drugs Sales by Country (2015-2020) (K Units)
Table 25. Europe Opioids Drugs Sales Market Share by Country (2015-2020)
Table 26. Europe Opioids Drugs Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Opioids Drugs Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Opioids Drugs Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Opioids Drugs Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Opioids Drugs Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Opioids Drugs Revenue Market Share by Region (2015-2020)
Table 32. Latin America Opioids Drugs Sales by Country (2015-2020) (K Units)
Table 33. Latin America Opioids Drugs Sales Market Share by Country (2015-2020)
Table 34. Latin America Opioids Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Opioids Drugs Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Opioids Drugs Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Opioids Drugs Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Opioids Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Opioids Drugs Revenue Market Share by Country (2015-2020)
Table 40. Global Opioids Drugs Sales (K Units) by Type (2015-2020)
Table 41. Global Opioids Drugs Sales Share by Type (2015-2020)
Table 42. Global Opioids Drugs Revenue (Million US$) by Type (2015-2020)
Table 43. Global Opioids Drugs Revenue Share by Type (2015-2020)
Table 44. Global Opioids Drugs Price (USD/Unit) by Type (2015-2020)
Table 45. Global Opioids Drugs Sales (K Units) by Application (2015-2020)
Table 46. Global Opioids Drugs Sales Market Share by Application (2015-2020)
Table 47. Global Opioids Drugs Sales Growth Rate by Application (2015-2020)
Table 48. Purdue Pharma Opioids Drugs Corporation Information
Table 49. Purdue Pharma Description and Business Overview
Table 50. Purdue Pharma Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Purdue Pharma Main Product
Table 52. Purdue Pharma Recent Development
Table 53. J&J Opioids Drugs Corporation Information
Table 54. J&J Corporation Information
Table 55. J&J Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. J&J Main Product
Table 57. J&J Recent Development
Table 58. Teva Opioids Drugs Corporation Information
Table 59. Teva Corporation Information
Table 60. Teva Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Teva Main Product
Table 62. Teva Recent Development
Table 63. Mylan Opioids Drugs Corporation Information
Table 64. Mylan Corporation Information
Table 65. Mylan Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Mylan Main Product
Table 67. Mylan Recent Development
Table 68. Depomed Opioids Drugs Corporation Information
Table 69. Depomed Corporation Information
Table 70. Depomed Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Depomed Main Product
Table 72. Depomed Recent Development
Table 73. INSYS Opioids Drugs Corporation Information
Table 74. INSYS Corporation Information
Table 75. INSYS Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. INSYS Main Product
Table 77. INSYS Recent Development
Table 78. Endo Opioids Drugs Corporation Information
Table 79. Endo Corporation Information
Table 80. Endo Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Endo Main Product
Table 82. Endo Recent Development
Table 83. Pfizer Opioids Drugs Corporation Information
Table 84. Pfizer Corporation Information
Table 85. Pfizer Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Pfizer Main Product
Table 87. Pfizer Recent Development
Table 88. Hikma Opioids Drugs Corporation Information
Table 89. Hikma Corporation Information
Table 90. Hikma Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Hikma Main Product
Table 92. Hikma Recent Development
Table 93. Mallinckrodt Opioids Drugs Corporation Information
Table 94. Mallinckrodt Corporation Information
Table 95. Mallinckrodt Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Mallinckrodt Main Product
Table 97. Mallinckrodt Recent Development
Table 98. Pernix Opioids Drugs Corporation Information
Table 99. Pernix Corporation Information
Table 100. Pernix Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Pernix Main Product
Table 102. Pernix Recent Development
Table 103. Egalet Opioids Drugs Corporation Information
Table 104. Egalet Corporation Information
Table 105. Egalet Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Egalet Main Product
Table 107. Egalet Recent Development
Table 108. Vistapharm Opioids Drugs Corporation Information
Table 109. Vistapharm Corporation Information
Table 110. Vistapharm Opioids Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Vistapharm Main Product
Table 112. Vistapharm Recent Development
Table 113. Sales Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Opioids Drugs Distributors List
Table 116. Opioids Drugs Customers List
Table 117. Market Key Trends
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Global Opioids Drugs Sales (K Units) Forecast by Type (2021-2026)
Table 121. Global Opioids Drugs Sales Market Share Forecast by Type (2021-2026)
Table 122. Global Opioids Drugs Revenue (Million US$) Forecast by Type (2021-2026)
Table 123. Global Opioids Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 124. Global Opioids Drugs Sales (K Units) Forecast by Application (2021-2026)
Table 125. Global Opioids Drugs Revenue (Million US$) Forecast by Application (2021-2026)
Table 126. Global Opioids Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 127. Global Opioids Drugs Sales Market Share Forecast by Region (2021-2026)
Table 128. Global Opioids Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Global Opioids Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Opioids Drugs
Figure 2. Global Opioids Drugs Sales Market Share by Type: 2020 VS 2026
Figure 3. Oxycodone Product Picture
Figure 4. Hydromorphone Product Picture
Figure 5. Codeine Product Picture
Figure 6. Fentanyl Product Picture
Figure 7. Other Product Picture
Figure 8. Global Opioids Drugs Consumption Market Share by Application: 2020 VS 2026
Figure 9. Pain Relief
Figure 10. Anesthesia
Figure 11. Other
Figure 12. Global Opioids Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Opioids Drugs Sales Capacity (K Units) (2015-2026)
Figure 14. Global Opioids Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Opioids Drugs Sales Share by Manufacturers in 2020
Figure 16. Global Opioids Drugs Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Opioids Drugs Revenue in 2019
Figure 18. Opioids Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Opioids Drugs Sales Market Share by Region (2015-2020)
Figure 20. Global Opioids Drugs Sales Market Share by Region in 2019
Figure 21. Global Opioids Drugs Revenue Market Share by Region (2015-2020)
Figure 22. Global Opioids Drugs Revenue Market Share by Region in 2019
Figure 23. North America Opioids Drugs Sales Market Share by Country in 2019
Figure 24. North America Opioids Drugs Revenue Market Share by Country in 2019
Figure 25. U.S. Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 26. U.S. Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 28. Canada Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Opioids Drugs Sales Market Share by Country in 2019
Figure 30. Europe Opioids Drugs Revenue Market Share by Country in 2019
Figure 31. Germany Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 32. Germany Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 34. France Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.K. Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. Italy Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 40. Russia Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Opioids Drugs Sales Market Share by Region in 2019
Figure 42. Asia Pacific Opioids Drugs Revenue Market Share by Region in 2019
Figure 43. China Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. China Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. Japan Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. South Korea Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. India Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Australia Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Taiwan Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 56. Indonesia Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 58. Thailand Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. Malaysia Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. Philippines Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. Vietnam Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Opioids Drugs Sales Market Share by Country in 2019
Figure 66. Latin America Opioids Drugs Revenue Market Share by Country in 2019
Figure 67. Mexico Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. Mexico Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Brazil Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Opioids Drugs Sales Market Share by Country in 2019
Figure 74. Middle East and Africa Opioids Drugs Revenue Market Share by Country in 2019
Figure 75. Turkey Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Turkey Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Saudi Arabia Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Saudi Arabia Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. U.A.E Opioids Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. U.A.E Opioids Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Sales Market Share of Opioids Drugs by Type (2015-2020)
Figure 82. Sales Market Share of Opioids Drugs by Type in 2019
Figure 83. Revenue Share of Opioids Drugs by Type (2015-2020)
Figure 84. Revenue Market Share of Opioids Drugs by Type in 2019
Figure 85. Global Opioids Drugs Sales Growth by Type (2015-2020) (K Units)
Figure 86. Global Opioids Drugs Sales Market Share by Application (2015-2020)
Figure 87. Global Opioids Drugs Sales Market Share by Application in 2019
Figure 88. Global Revenue Share of Opioids Drugs by Application (2015-2020)
Figure 89. Global Revenue Share of Opioids Drugs by Application in 2020
Figure 90. Purdue Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. J&J Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Depomed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. INSYS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Endo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Hikma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Pernix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Egalet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Vistapharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Price Trend of Key Raw Materials
Figure 104. Manufacturing Cost Structure of Opioids Drugs
Figure 105. Manufacturing Process Analysis of Opioids Drugs
Figure 106. Opioids Drugs Industrial Chain Analysis
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Porter's Five Forces Analysis
Figure 110. North America Opioids Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 111. North America Opioids Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Europe Opioids Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 113. Europe Opioids Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Latin America Opioids Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 115. Latin America Opioids Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Middle East and Africa Opioids Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 117. Middle East and Africa Opioids Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Asia Pacific Opioids Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 119. Asia Pacific Opioids Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pain Management Drugs Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......

Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......

Global Opioids Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......

Global Methadone Hydrochloride Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......

Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......

Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111

According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......

Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87

According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......

Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131

According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......

Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167

The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs